What was the market valuation of the US transdermal drug-delivery-systems market in 2024?

The market valuation was $7.42 Billion in 2024. Read More

What is the projected market valuation for the US transdermal drug-delivery-systems market by 2035?

The projected valuation for 2035 is $13.12 Billion. Read More

What is the expected CAGR for the US transdermal drug-delivery-systems market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 5.32%. Read More

Which technology segment is expected to show significant growth in the US transdermal drug-delivery-systems market?

The Transdermal Patches segment is anticipated to grow from $3.56 Billion to $6.12 Billion. Read More

What are the key applications driving the US transdermal drug-delivery-systems market?

Key applications include Pain Management, Hormone Replacement Therapy, and Smoking Cessation. Read More

How does the market for Pain Management compare to other applications in 2024?

In 2024, the Pain Management application was valued at $2.5 Billion. Read More

What is the expected growth of the Home Healthcare segment in the US transdermal drug-delivery-systems market?

The Home Healthcare segment is projected to grow from $2.22 Billion to $4.0 Billion. Read More

Which formulation type is expected to dominate the US transdermal drug-delivery-systems market?

The Drug-in-Patch formulation type is expected to grow from $2.22 Billion to $3.92 Billion. Read More

Who are the key players in the US transdermal drug-delivery-systems market?

Key players include Johnson & Johnson, Mylan N.V., and Novartis AG. Read More

What is the projected growth for the Iontophoresis technology segment by 2035?

The Iontophoresis segment is expected to grow from $1.11 Billion to $1.95 Billion by 2035. Read More

US Transdermal Drug Delivery Systems Market

ID: MRFR/Pharma/14855-HCR

100 Pages

Vikita Thakur

Last Updated: April 24, 2026

US Transdermal Drug Delivery Systems Market Research Report: Size, Share, Trend Analysis By Product (Transdermal Patches, Semisolids) and By Technology (Electric Current, Iontophoresis, Electroporation, Ultrasound, Microporation) - Growth Outlook & Industry Forecast 2025 To 2035

US Transdermal Drug Delivery Systems Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Technology (USD Billion)
  1. 4.1.1 Microneedle Patches
  2. 4.1.2 Transdermal Patches
  3. 4.1.3 Iontophoresis
  4. 4.1.4 Sonophoresis
  5. 4.1.5 Thermal Patches
2. 4.2 Healthcare, BY Application (USD Billion)
  1. 4.2.1 Pain Management
  2. 4.2.2 Hormone Replacement Therapy
  3. 4.2.3 Cardiovascular Diseases
  4. 4.2.4 Neurological Disorders
  5. 4.2.5 Smoking Cessation
3. 4.3 Healthcare, BY End-use (USD Billion)
  1. 4.3.1 Hospitals
  2. 4.3.2 Home Healthcare
  3. 4.3.3 Pharmaceutical Companies
  4. 4.3.4 Research Institutes
4. 4.4 Healthcare, BY Formulation Type (USD Billion)
  1. 4.4.1 Drug-in-Patch
  2. 4.4.2 Reservoir Type
  3. 4.4.3 Matrix Type
  4. 4.4.4 Microreservoir Type
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Johnson & Johnson (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Mylan N.V. (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Novartis AG (CH)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Boehringer Ingelheim (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Teva Pharmaceutical Industries Ltd. (IL)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Hikma Pharmaceuticals PLC (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Purdue Pharma L.P. (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 AstraZeneca PLC (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Ferring Pharmaceuticals (CH)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TECHNOLOGY
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY END-USE
5. 6.5 US MARKET ANALYSIS BY FORMULATION TYPE
6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF HEALTHCARE
9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
12. 6.12 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
13. 6.13 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion)
14. 6.14 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
15. 6.15 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
16. 6.16 HEALTHCARE, BY END-USE, 2024 (% SHARE)
17. 6.17 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Billion)
18. 6.18 HEALTHCARE, BY FORMULATION TYPE, 2024 (% SHARE)
19. 6.19 HEALTHCARE, BY FORMULATION TYPE, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TECHNOLOGY, 2025-2035 (USD Billion)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Billion)
  3. 7.2.3 BY END-USE, 2025-2035 (USD Billion)
  4. 7.2.4 BY FORMULATION TYPE, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Healthcare Market Segmentation

Healthcare By Technology (USD Billion, 2025-2035)

Microneedle Patches
Transdermal Patches
Iontophoresis
Sonophoresis
Thermal Patches

Healthcare By Application (USD Billion, 2025-2035)

Pain Management
Hormone Replacement Therapy
Cardiovascular Diseases
Neurological Disorders
Smoking Cessation

Healthcare By End-use (USD Billion, 2025-2035)

Hospitals
Home Healthcare
Pharmaceutical Companies
Research Institutes

Healthcare By Formulation Type (USD Billion, 2025-2035)

Drug-in-Patch
Reservoir Type
Matrix Type
Microreservoir Type

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”